Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Life Medical Sciences (CHAI) for Hair Regrowth? -- Ignore unavailable to you. Want to Upgrade?

To: GregSL who wrote (1128)	2/10/2000 8:23:00 PM
From: Gregory Messenger	Read Replies (1) \| Respond to of 1152

Greg, I can second Marc's post. I've been around since May, 1993. Art, Marc, myself, Brad and others have been around. Frankly, I'm the really old timer but I've grown to appreciate and respect that the others I mentioned know alot about Chai's Repel potential and the scientific basis behind it-more than I do, that's for sure. Moskowitz founded the company, a very smooth and savvy individual. Been on CNBC, very impressive talker-the analysts liked him-polished and confident. He really played up Piliel and later Clinicel-both were complete flops and Hickey knew it from the start. In fact, I think the trumpeting of those products made Bob very uncomfortable, but he was concentrating on the golden goose-Repel and Repel CV. However, to Moskowitz credit, he is the largest shareholder and has continued to sink additional personal capital into Chai, including the recent private placement. Hickey has taken complete control of the company, Moskowitz stepped down as Chaiman/CEO in August-after he bought more in the PP. Also to Moskowitz credit, he was smart enough to get Hickey and Eli Pines. He also stepped down-I can only speculate on the reasons for that but I think Hickey has a better chance of pulling this off with Herb behind the scenes, instead of out front. Frankly, I think having Herb as the spokesperson in a transaction with a medical suitor would make both sides uncomfortable-just my opinion. So, in a sense, I'm hoping that Herb took a bullet for the team. I agree with Marc's speculation that Hickey is probably under some time deadline to pull off a deal suitable to both parties-and shareholders. Bob Hickey is a no nonsense kind of guy. In my opinion, he really tends to underemphasize things, so if you get Bob to say that something is going well it's kind of like most people saying that something is going incredibly perfect. I think Bob is very careful about raising people's expectations, particularly in light of the past public relations mistakes made by Moskowitz-talk about raising expectations! Bottom line in my opinion-very little downside risk at these prices. I think Chai will ultimately bring Repel to market or they will partner or they will be bought out. Under any of these scenarios, I do not see the transaction going at the current stock price, or anywhere close to the current stock price. One other point that I think is really important. This company still has just under or just over 10,000,000 shares out. I do not view that as alot of shares in todays market, in fact I view it as extremely responsible. I can't begin to tell you how many companies I've researched recently in the "speculative" area that have 20, 30 and even 60 million shares out already-frightening-talk about dilution. I'm starting to ramble. Hope this helps you in some way. Mess